Showing 301-310 of 350 grants

Title Institution Researcher Program Duration Total Award Amount
Closing the T1D diagnosis gap in Ethiopia, Ghana and Nigeria Clinton Health Access Initiative (CHAI) Margaret Prust Mission 01-September-2023 to 31-August-2026 $1.702.076,57
Acute Hyperglycemia Promotes a Proinflammatory Monocyte Phenotype to Drive Glomerular Injury in People with Diabetic Kidney Disease and Type 1 Diabetes Cleveland Clinic Foundation Rong Mei Zhang Improving Lives 01-July-2026 to 31-December-2027 $74.999,40
Spotlight-AQ 2 Center RCT Children’s Mercy Hospital Cintya Schweisberger Improving Lives 01-September-2023 to 31-August-2026 $710.434,16
Leveraging humoral immunity to promote commensal microbial protection from T1D Children’s Hospital of Philadelphia Michael Silverman Cures 01-May-2020 to 30-April-2026 $749.994,60
Engineering and Translational Control of Vascularization for Durable Islet Replacement Therapies Cedars-Sinai Medical Center Dhruv Sareen Cures 01-October-2026 to 30-September-2029 $899.998,80
Scalable GMP-Compliant Manufacturing of iPSC-Derived Insulin-Producing Cells: From Seed Train to Cryopreserved Product Cedars-Sinai Medical Center Dhruv Sareen Cures 01-April-2026 to 31-March-2028 $600.000,00
microRNA-146a is a potential therapeutic target for type 1 diabetes Case Western Reserve University Parameswaran Ramakrishnan Cures 01-June-2024 to 31-May-2027 $600.000,00
Novel mechanism and method to control T cell mediated autoimmunity in type 1 diabetes Case Western Reserve University Parameswaran Ramakrishnan Cures 01-June-2022 to 31-May-2027 $600.000,00
Pro-Angiogenic and Immune-Modulatory Scaffolds for the Functional Engraftment of Islets in the Subcutaneous Space Carnegie Mellon University Adam Feinberg Cures 01-November-2024 to 31-October-2027 $950.000,00
Local bioelectronic oxygenation for islet engraftment Carnegie Mellon University Tzahi Cohen-Karni Cures 01-August-2024 to 31-July-2027 $974.998,74